Filing Details
- Accession Number:
- 0001437749-25-019583
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-05 17:15:00
- Reporting Period:
- 2025-06-03
- Filing Date:
- 2025-06-05
- Accepted Time:
- 2025-06-05 17:15:00
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1710340 | Eton Pharmaceuticals Inc. | ETON | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1669976 | Sean Brynjelsen | C/O Eton Pharmaceuticals, Inc. 21925 W. Field Parkway, Suite 235 Deerpark IL 60010-7208 | President & Ceo | Yes | Yes | Yes | No |
Transaction Summary
| Sold: | 210,000 shares | Avg. Price: $17.11 | Total Value: $3,592,611.00 |
| Number of Shares After Transactions: | 2,873,513 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-06-03 | 60,945 | $17.38 | 3,022,568 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-06-03 | 8,655 | $18.38 | 3,013,913 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-06-03 | 400 | $19.02 | 3,013,513 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-06-04 | 70,000 | $17.00 | 2,943,513 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-06-05 | 70,000 | $16.81 | 2,873,513 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The shares were sold in multiple trades at prices ranging from $17.00 to $17.88. The price reported above reflects the weighted average sales price.
- The shares were sold in multiple trades at prices ranging from $18.15 to $18.85. The price reported above reflects the weighted average sales price.
- The shares were sold in multiple trades at a price of $19.02.
- The shares were sold in multiple trades at prices ranging from $16.86 to $17.20. The price reported above reflects the weighted average sales price.
- The shares were sold in multiple trades at prices ranging from $16.62 to $17.15. The price reported above reflects the weighted average sales price.
- The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
